Isomorphic Labs to Begin Human Trials of AI-Designed Drugs From DeepMind Spinoff
Isomorphic Labs, a Google DeepMind spinoff, will soon start human trials of drugs designed using its Nobel Prize–winning AI protein-folding technology.
Isomorphic Labs, a Google DeepMind spinoff, will soon start human trials of drugs designed using its Nobel Prize–winning AI protein-folding technology.
10x Science has raised a $4.8 million seed round to help pharmaceutical researchers evaluate the growing flood of AI-generated potential drug molecules.
Anthropic purchased stealth AI biotech startup Coefficient Bio for $400M in stock, marking a major push into AI-driven drug discovery and biological research.
AI biotech startup Chai Discovery completes Series B funding and announces partnership with Eli Lilly to accelerate drug discovery using generative design models.